Question-and-Answer SessionAbsolutely. Welcome you. Okay. So Jim, if you can just give us a little bit kind of an overview of the Novavax today. I think it's different from last year for sure, and then the very big strategic focus for the new Novavax. And then why don't you give us an overview?James KellyExecutive VP, CFO & Treasurer Right. Fantastic. So thanks, everyone, for joining us today. For many of you, you may be familiar with Novavax from our most recent history during the pandemic. One of the very ...